ORLISTAT /GEMFIBROZIL AMELIORATE TESTICULAR DYSFUNCTION IN STREPTOZOTOCIN-INDUCED DIABETES IN RATS VIA TARGETING VEGF/ NO / PROGRAMMED CELL DEATH FACTOR 4 SIGNALING PATHWAYS
Tahoon, D., khattab, H., Nasif, E., Elkholy, R., Elseady, W., Hamama, M., Saadawy, S., ElKholy, R. (2023). ORLISTAT /GEMFIBROZIL AMELIORATE TESTICULAR DYSFUNCTION IN STREPTOZOTOCIN-INDUCED DIABETES IN RATS VIA TARGETING VEGF/ NO / PROGRAMMED CELL DEATH FACTOR 4 SIGNALING PATHWAYS. EKB Journal Management System, 46(1), 597-614. doi: 10.21608/bfsa.2023.301261
Dina M. Tahoon; Haidy khattab; Elham Nasif; Rasha A. Elkholy; Walaa S. Elseady; Mohamed G. Hamama; Sara F. Saadawy; Reem A. ElKholy. "ORLISTAT /GEMFIBROZIL AMELIORATE TESTICULAR DYSFUNCTION IN STREPTOZOTOCIN-INDUCED DIABETES IN RATS VIA TARGETING VEGF/ NO / PROGRAMMED CELL DEATH FACTOR 4 SIGNALING PATHWAYS". EKB Journal Management System, 46, 1, 2023, 597-614. doi: 10.21608/bfsa.2023.301261
Tahoon, D., khattab, H., Nasif, E., Elkholy, R., Elseady, W., Hamama, M., Saadawy, S., ElKholy, R. (2023). 'ORLISTAT /GEMFIBROZIL AMELIORATE TESTICULAR DYSFUNCTION IN STREPTOZOTOCIN-INDUCED DIABETES IN RATS VIA TARGETING VEGF/ NO / PROGRAMMED CELL DEATH FACTOR 4 SIGNALING PATHWAYS', EKB Journal Management System, 46(1), pp. 597-614. doi: 10.21608/bfsa.2023.301261
Tahoon, D., khattab, H., Nasif, E., Elkholy, R., Elseady, W., Hamama, M., Saadawy, S., ElKholy, R. ORLISTAT /GEMFIBROZIL AMELIORATE TESTICULAR DYSFUNCTION IN STREPTOZOTOCIN-INDUCED DIABETES IN RATS VIA TARGETING VEGF/ NO / PROGRAMMED CELL DEATH FACTOR 4 SIGNALING PATHWAYS. EKB Journal Management System, 2023; 46(1): 597-614. doi: 10.21608/bfsa.2023.301261